More than a taste ıssue: multidimensional gaps in addressing chemotherapy-ınduced dysgeusia.

Chemotherapy-induced taste alterations are a prevalent but frequently under-recognized complication with significant nutritional and psychosocial consequences. In this letter, we offer a critical appraisal of the recent study by Köksal et al., highlighting key gaps that limit its translational applicability. We emphasize the importance of accounting for comorbid conditions, psychosocial impacts, and treatment-specific factors-such as variability among chemotherapeutic agents and adjunct medications. Additionally, we advocate for a multidisciplinary approach to better address dysgeusia in clinical oncology. Our commentary aims to broaden the clinical perspective on dysgeusia and support more comprehensive supportive care strategies.